COMT, BDNF, and DTNBP1 polymorphisms and cognitive functions in patients with brain tumors
- PMID: 27091610
- PMCID: PMC5035520
- DOI: 10.1093/neuonc/now057
COMT, BDNF, and DTNBP1 polymorphisms and cognitive functions in patients with brain tumors
Abstract
Background: Cognitive dysfunction is common among patients with brain tumors and can be associated with the disease and treatment with radiotherapy and chemotherapy. However, little is known about genetic risk factors that may moderate the vulnerability for developing cognitive dysfunction. In this study, we examined the association of single nucleotide polymorphisms (SNPs) in the catechol-O-methyl transferase (COMT), brain-derived neurotrophic factor (BDNF), and dystrobrevin-binding protein 1 (DTNBP1) genes with cognitive functions and neuroimaging outcomes in patients with brain tumors.
Methods: One hundred and fifty patients with brain tumors completed neuropsychological tests of attention, executive functions, and memory and were genotyped for polymorphisms in the COMT, BDNF, and DTNBP1 genes. Ratings of white matter (WM) abnormalities on magnetic resonance imaging scans were performed.
Results: Multivariate regression shrinkage analyses, adjusted for age, education, treatment type, time since treatment completion, and tumor location, indicated a significant association between the COMT SNP rs4680 (Val158Met) and memory with lower scores in delayed recall (P < .01) among homozygotes (valine/valine). Additional COMT, BDNF and DTNBP1 SNPs were significantly associated with attention, executive functions, and memory scores.
Conclusion: This is the first study to suggest that known and newly described polymorphisms in genes associated with executive and memory functions in healthy individuals and other clinical populations may modulate cognitive outcome in patients with brain tumors.
Keywords: BDNF; COMT; DTNBP1; brain tumors, cognitive.
© The Author(s) 2016. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Similar articles
-
The effect of COMT, BDNF, 5-HTT, NRG1 and DTNBP1 genes on hippocampal and lateral ventricular volume in psychosis.Psychol Med. 2009 Nov;39(11):1783-97. doi: 10.1017/S0033291709990316. Epub 2009 Jul 2. Psychol Med. 2009. PMID: 19573260
-
A quantitative association study between schizotypal traits and COMT, PRODH and BDNF genes in a healthy Chinese population.Psychiatry Res. 2007 Sep 30;153(1):7-15. doi: 10.1016/j.psychres.2007.02.003. Epub 2007 Jun 29. Psychiatry Res. 2007. PMID: 17604122
-
BDNF and COMT polymorphisms have a limited association with episodic memory performance or engagement in complex cognitive activity in healthy older adults.Neurobiol Learn Mem. 2014 Apr;110:1-7. doi: 10.1016/j.nlm.2014.01.013. Epub 2014 Jan 24. Neurobiol Learn Mem. 2014. PMID: 24468545
-
The impact of COMT polymorphisms on cognition in Bipolar Disorder: A review: Special Section on "Translational and Neuroscience Studies in Affective Disorders" Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders.J Affect Disord. 2019 Jan 15;243:545-551. doi: 10.1016/j.jad.2018.08.009. Epub 2018 Aug 8. J Affect Disord. 2019. PMID: 30146088 Review.
-
Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology.Schizophr Bull. 2006 Jan;32(1):9-16. doi: 10.1093/schbul/sbj033. Epub 2005 Nov 30. Schizophr Bull. 2006. PMID: 16319375 Free PMC article. Review.
Cited by
-
Genetic variants and cognitive functions in patients with brain tumors.Neuro Oncol. 2019 Oct 9;21(10):1297-1309. doi: 10.1093/neuonc/noz094. Neuro Oncol. 2019. PMID: 31123752 Free PMC article.
-
A pilot study of neuropsychological functions, APOE and amyloid imaging in patients with gliomas.J Neurooncol. 2018 Feb;136(3):613-622. doi: 10.1007/s11060-017-2692-5. Epub 2017 Nov 22. J Neurooncol. 2018. PMID: 29168082 Free PMC article.
-
Brain radiotoxicity-related 15CAcBRT gene expression signature predicts survival prognosis of glioblastoma patients.Neuro Oncol. 2023 Feb 14;25(2):303-314. doi: 10.1093/neuonc/noac171. Neuro Oncol. 2023. PMID: 35802478 Free PMC article.
-
Neuropsychological Outcomes of Children Treated for Brain Tumors.Children (Basel). 2023 Feb 27;10(3):472. doi: 10.3390/children10030472. Children (Basel). 2023. PMID: 36980030 Free PMC article. Review.
-
Prognostic Prediction Model for Glioblastoma: A Metabolic Gene Signature and Independent External Validation.J Cancer. 2021 May 5;12(13):3796-3808. doi: 10.7150/jca.53827. eCollection 2021. J Cancer. 2021. PMID: 34093788 Free PMC article.
References
-
- Behin A, DeLattre JY. Neurologic sequelae of radiotherapy on the nervous system. In: Schiff D, Wen PY eds. Cancer Neurology in Clinical Practice. Totowa, New Jersey: Humana Press; 2003:173–191.
-
- Correa DD, Zhou Q, Thaler HT et al. . Cognitive functions in long-term survivors of ovarian cancer. Gynecol Oncol. 2010;119 (2):366–369. - PubMed
-
- Meyers CA, Brown PD. Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors. J Clin Oncol. 2006;24 (8):1305–1309. - PubMed
-
- Goldberg TE, Weinberger DR. Genes and the parsing of cognitive processes. Trends Cogn Sci. 2004;8 (7):325–335. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous